Targeting factors that help the heart and lungs adapt to low oxygen levels
Official title: Targeting Hypoxia-Inducible Factors (HIFs) for Heart and Lung Disease
Funded at University of Texas Hlth Sci Ctr Houston · NIH-11037681 · Data updated 2026-11-12
This study is looking at how certain proteins that help our bodies respond to low oxygen can be used to improve treatment for heart and lung diseases, especially during serious conditions like ARDS and heart attacks, so that patients can recover better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | March 1, 2025 |
| Project end | December 31, 2031 |
| Funding year | 2025 |
| Award (this year) | $564,445 |
| NIH project number | 1R35HL177402-01 |
| Project ID | NIH-11037681 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals suffering from acute respiratory distress syndrome or other related heart and lung conditions.
✕Less likely to help
Patients with stable heart and lung conditions who do not experience acute episodes may not receive benefit from this research.
What this research studies
This research investigates how hypoxia-inducible factors (HIFs) can be targeted to improve outcomes in heart and lung diseases, particularly during conditions like acute respiratory distress syndrome (ARDS) and myocardial ischemia. The study focuses on understanding how these factors are stabilized during low oxygen levels and inflammation, and how they can help reduce excessive tissue damage. By exploring the roles of different HIF isoforms and their specific functions in various tissues, the research aims to develop new therapeutic strategies that could enhance patient recovery. Patients may benefit from insights gained into how to better manage their conditions through targeted therapies.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and outcomes for patients with heart and lung diseases.
How similar studies have gone: Previous research has shown promising results in targeting hypoxia-inducible factors for therapeutic purposes, indicating potential for success in this approach.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Eltzschig, Holger K. — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Eltzschig, Holger K.
Related research
Other NIH-funded projects on the same topics.
-
Using MRI to measure brain oxygen levels as an early sign of small vessel disease in the brain
This study is looking at how measuring oxygen levels in the brain with MRI can help spot early signs of small vessel disease, which is linked to memory problems and dementia, especially Alzheimer's, so if you're at risk due to age or high blood pressure, you might be able to participate in MRI scans to learn more about
-
HIF-driven ways to repair damaged lungs in IPF
A doctor-researcher is testing how low-oxygen signals (HIF) could help restore healthy lung tissue in people with IPF.
-
Neonatal Brain Injury Protection with New Purine Compounds
A new medication approach using purine derivatives is being studied to protect newborn brains from injury caused by limited blood flow and oxygen during birth.
-
Aldo-keto reductase (AKR) helps brain BH4 levels after injury
This grant tests whether brain AKR enzymes can boost BH4 levels and support better brain function after hypoxia-ischemia-related injury.
-
Dual-hypoxia and proliferation PET biomarker for recurrent glioblastoma
A study using a special PET imaging approach to map oxygen-poor areas and cell growth in recurrent brain tumors to guide treatment decisions.
-
How low oxygen and genetic tweaks may repair mitochondrial problems linked to Alzheimer’s and other disorders
A Johns Hopkins-style? (Note: institution specified later) patient-facing overview: researchers will study tiny cell power stations in mitochondria to see if low-oxygen conditions and specific genetic changes can fix problems associated with Alzheimer's disease and related dementias.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.